Qing Tang

Qing Tang

Auto-generated profile, based on publicly available information

Qing Tang

Institute of Neuroscience, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
QTQing Tang
Qing Tang
MLMingming Liu
Mingming Liu
YLYang Liu
Yang Liu
RHRan‐Der Hwang
Ran‐Der Hwang
TZTao Zhang
Tao Zhang
JWJiou Wang
Jiou Wang
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

10 February 2024 in Journal of Environmental Chemical Engineering
Verified
Journal Article
Closed access
ZZZhijuan Zeng
Zhijuan Zeng
QTQing Tang
Qing Tang
Bin WenBin Wen
Bin Wen
Lan LuoLan Luo
Lan Luo
Xianxiang LiuXianxiang Liu
Xianxiang Liu
WZWenzhou Zhong
Wenzhou Zhong

10 July 2024 in Neural Regeneration Research
Verified
Journal Article
Open access
ZLZhimin Long
Zhimin Long
CGChuanhua Ge
Chuanhua Ge
YZYueyang Zhao
Yueyang Zhao
YLYuanjie Liu
Yuanjie Liu
QZQinghua Zeng
Qinghua Zeng
GHguiqiong He
guiqiong He
JOURNAL/nrgr/04.03/01300535-202509000-00025/figure1/v/2026-04-27T065306Z/r/image-tiff Recent studies have suggested that abnormal acidification of lysosomes induces autophagic accumulation of amyloid-β in neurons, which is a key step in senile plaque formation. Therefore, restoring normal lysosomal function and rebalancing lysosomal acidification in neurons in the brain may be a new treatment strategy for Alzheimer’s disease. Microtubule acetylation/deacetylation plays a central role in lysosomal acidification. Here, we show that inhibiting the classic microtubule deacetylase histone deacetylase 6 with an histone deacetylase 6 shRNA or thehistone deacetylase 6 inhibitor valproic acid promoted lysosomal reacidification by modulating V-ATPase assembly in Alzheimer’s disease. Furthermore, we found that treatment with valproic acid markedly enhanced autophagy, promoted clearance of amyloid-β aggregates, and ameliorated cognitive deficits in a mouse model of Alzheimer’s disease. Our findings demonstrate a previously unknown neuroprotective mechanism in Alzheimer’s disease, in which histone deacetylase 6 inhibition by valproic acid increases V-ATPase assembly and lysosomal acidification.

1 April 1991 in Carcinogenesis
Verified
Journal Article
Closed access
PDF file
ADAyumi Denda
Ayumi Denda
KSKimie Sai
Kimie Sai
QTQing Tang
Qing Tang
TTToshifumi Tsujiuchi
Toshifumi Tsujiuchi
MTMasahiro Tsutsumi
Masahiro Tsutsumi
YKYoichi Konishi
Yoichi Konishi
Inducibility of oxidative stress in rat liver in vivo by menadone-associated redox cycling activation under redox enzyme modulating conditions was examined by monitoring hepatocyte injury and 8-hydroxydeoxyguanosine (8-OHdG) levels of liver DNA. In addition, the treatment-associated liver tumor initiating activity was assessed in terms of development of γ-glutamyl-transpeptidase (GGT)- and glutathione S-transferase placental form (GST-P)-pitive foci and hyperplastic nodules. With or without following menadione treatment (50 mg/kg, i.g.), redox enzyme modulations of increased cytochrome P450 reductase activity induced by phenobarbital (PB)-Na (100 mg/kg, i.p. for 5 days), inhibition of DT-diaphorase by dicumarol (25 mg/kg, i.p.) and depletion of glutathione by phorone (200 mg/kg, i.p.), with or without further supplement of iroo EDTA-Na-Fe(III) (70 mg/kg, i.p.), caused both substantial hepatocyte necrosis and 8-OHdG production in Fischer 344 male rats. Subsequent feeding with a 0.05% PB diet for 64 weeks resulted in slightty increased development of GGT-positive foci but not GST-P positive lesions or hyperplastic nodules, suggesting a lack of tumor-initiating activity of the oxidative DNA damage associated with redox enzyme modulations with or without menadione.

1 July 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
CCChu Chen
Chu Chen
FMFang Ma
Fang Ma
XWXinli Wen
Xinli Wen
XLXing Liu
Xing Liu
QTQing Tang
Qing Tang
YWYilun Wu
Yilun Wu
Objective: The study aimed to evaluate the clinical efficacy of the Huo Xue Hua Yu method combined with aspirin in the treatment of patients with acute cerebral infarction (ACI). Methods: By searching electronic databases, such as the Chinese Biomedical Literature Database (CBM), the China National Knowledge Infrastructure Database (CNKI), the China Science and Technology Journal Database, Wanfang, PubMed, Embase, and the Cochrane Library, all randomized controlled trials (RCTs) published before 14 July, 2022, and published in Chinese or English languages were selected. Statistical analysis was performed using Review Manager 5.4 calculation software to calculate the odds ratio (OR), mean difference (MD), 95% confidence interval (CI), and p values. Results: 13 articles that included 1,243 patients were identified; in 646 of them, the Huo Xue Hua Yu method combined with aspirin has been administered, while 597 have only been administered aspirin therapy. The combined treatment significantly improved clinical efficacy (OR: 4.41, 95% CI: 2.90 to 5.84, p < 0.001, I2 = 0), as assessed by the National Institutes of Health Stroke Scale score (MD = -4.18, 95% CI: -5.69 to -2.67, p < 0.001, I2 = 94%), Barthel score (MD = -2.23, 95% CI: -2.66 to -1.81, p < 0.001, I2 = 82%), the China Stroke Scale score (MD = 6.74, 95% CI: -3.49 to 16.96, P = 0.20, I2 = 99%), packed cell volume (MD = -8.45, 95% CI: -8.81 to -8.09, p < 0.001, I2 = 98%), fibrinogen levels (MD = -0.93, 95% CI: -1.23 to -0.63, p < 0.001, I2 = 78%) and plasma viscosity (MD = -0.51, 95% CI: -0.72 to -0.30, p < 0.001, I2 = 62%). Conclusion: The combination of the Huo Xue Hua Yu method and aspirin represents a beneficial adjunctive therapy for ACI.